About Genewiz
Genewiz is a Healthcare company based in South Plainfield (United States) founded in 1999 by Amy Liao and Steve Sun, and was acquired by Brooks Automation in September 2018. Genomic services are provided for the life sciences industry. The company has 452 employees. Genewiz has completed 1 acquisition, including Beckman Coulter Genomics. Its chief executive, as recorded, is Amy Liao. Its website genewiz.com draws about 219 thousand monthly visits. Genewiz offers products and services including Next Generation Sequencing, Sanger Sequencing, Gene Synthesis, Plasmid Preparation, and Oligo Synthesis. Its focus areas include Life Sciences, Genomics, Genomics Services and Full Service. Its competitors include Rejuvenate Bio and 20n; 2 of its 2 listed competitors have raised funding.
Company details
Genewiz was founded in 1999 and is headquartered in South Plainfield, United States. Operations focus on the life sciences sector, where a variety of genomic services are delivered, including DNA sequencing, gene synthesis, plasmid preparation, site-directed mutagenesis, fragment analysis, SNP discovery sequencing, next-generation sequencing, bioinformatics, and GLPcGMP regulatory support. Molecular biology services are also offered to support research and development needs.
- Headquarters South Plainfield, United States
- Employees 452
- Founders Amy Liao, Steve Sun
- Stage Acquired
- SectorsHealthcare
- Website genewiz.com
- Social LinkedIn X
- Acquired by Brooks Automation (Sep 2018)
- Latest Funding Round$143.28K (USD), Grant
Jun 2020
- InvestorsBrooks Automation
& 4 more
- Employee Count452
- Investments & Acquisitions
- Acquired byBrooks Automation
(Sep 2018)
Products & Services of Genewiz
Genewiz offers a comprehensive portfolio of products and services, including Next Generation Sequencing, Sanger Sequencing, Gene Synthesis, Plasmid Preparation, and Oligo Synthesis.
High-throughput DNA sequencing for research applications
Accurate DNA sequencing for mutation analysis
Custom DNA and RNA synthesis for experiments
Standard and targeted plasmid DNA prep services
Custom DNA and RNA oligos for sequencing
Funding Insights of Genewiz
- Total Rounds 2
- Last Round Grant — $143,283
- Investors Count 4
All 2 funding rounds of Genewiz with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2020 | $143,283 | Grant | – | – | |
| Jan 2016 | Private Equity Round | – | – |
5 investors in total: 5 institutional.
Investors in Genewiz
Genewiz has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Brooks Automation, Orbimed and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
Ampersand Capital Partners is focused on investments in healthcare and life sciences. | ampersandcapital.com | Boston, United States | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Manages an infrastructure fund specializing in the energy sector. | 2009 | primevaluecm.com | Dublin, Ireland | |
Vacuum robots for semiconductor wafer handling are developed. | 1978 | brooks.com | Chelmsford, United States |
Investor details for Genewiz
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Genewiz
266 people are tracked at Genewiz (65 in leadership, 7 in board & advisors, 194 in team); the tracked headcount is 452.
| Name | Role | Group |
|---|---|---|
Amy Liao | Co-Founder & CEO | Leadership |
Steve Sun | Co-Founder | Leadership |
Nicole Siegler | Senior Director, Assistant General Counsel | Leadership |
Samir Dilawari | Senior Director Of Accounting | Leadership |
Nick Garside | Director - Key Account Management - Life Science Products | Leadership |
Derek Stenli | Head Of Corporate Fp&a And Finance Operations | Leadership |
Cheryl Morrison | Director, Regional Sales | Leadership |
Michael Paulo | VP, Chief Information & Digital Officer | Leadership |
Ginger Zhou | VP & GM, Genomic Services | Leadership |
Stephen S. Schwartz | President & CEO | Leadership |
Christopher Mozdzierz | Senior Director & General Manager - Americas Region | Leadership |
Rupa Duhra Ark | Senior Director Global Sales Consumables And Instruments | Leadership |
David C. Gray | SVP & Chief Strategy & New Business Officer | Leadership |
Shirley Mai | Human Resources Business Partner | Leadership |
Yu Zheng | Associate Director | Leadership |
Jeffrey Otto | Senior Business Director, Laboratory Services | Leadership |
Haythem Latif | Sr Director & GM Global NGS & Clinical Services | Leadership |
Rui Fan | Director, Technical Support And Business Development | Leadership |
David Pevzner | Senior Director, North America, Sales | Leadership |
Bill Foss | Director Revenue Accounting | Leadership |
246 more people are available in the full profile.
Complete people profiles for Genewiz
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genewiz
Genewiz has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Beckman Coulter Genomics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Next-generation and Sanger sequencing services are provided. | beckmangenomics.com | Danvers, United States | 2008 | Dec 2015 | •••• |
Complete acquisition details for Genewiz
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Genewiz
5 dated milestones of Genewiz across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Genewiz is founded.
- Acquisition Acquires Beckman Coulter Genomics.
- Funding First funding round.
- Exit Acquired by Brooks Automation.
- Funding Latest funding round, Grant, of $143K.
Competitors of Genewiz
Genewiz has 2 listed competitors in our database, 2 of them funded. They include Rejuvenate Bio and 20n.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| 20n.com | 2013 | San Francisco, United States | $2.22M | Computational tools are developed to engineer microbes for synthetic biology. |
Detailed competitors of Genewiz
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Genewiz
The website of Genewiz (genewiz.com) receives about 218.6K visits a month.
- Monthly visits218.6K
▼ 1.1% vs previous month
Websites whose visitors overlap most with Genewiz. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| idtdna.com | 100% | 505.8K | #85,096 | View details | |
| azenta.com | 83% | 142.4K | #244,494 | View details | |
| genscript.com | 79% | 456.1K | #94,888 | View details | |
| benchling.com | 73% | 1.4M | #36,159 | View details | |
| etonbio.com | 72% | 15.4K | #1,163,824 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Genewiz
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Genewiz (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genewiz
Complete news archive for Genewiz
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genewiz
Genewiz was founded in 1999 and raised its 1st funding round 17 years after it was founded.
Genewiz is headquartered in South Plainfield, United States. It is registered at South Plainfield, New Jersey, United States.
Amy Liao is the CEO of Genewiz, as recorded in our data. They have also founded this company.
Genewiz has 452 employees.
Genewiz was founded in 1999 and is headquartered in South Plainfield, United States. Operations focus on the life sciences sector, where a variety of genomic services are delivered, including DNA sequencing, gene synthesis, plasmid preparation, site-directed mutagenesis, fragment analysis, SNP discovery sequencing, next-generation sequencing, bioinformatics, and GLPcGMP regulatory support. Molecular biology services are also offered to support research and development needs.
Genewiz's top competitors include Rejuvenate Bio and 20n.
Genewiz offers Next Generation Sequencing, Sanger Sequencing, Gene Synthesis, Plasmid Preparation, and Oligo Synthesis.
Genewiz has made 1 acquisition, including Beckman Coulter Genomics.
Genewiz has 5 investors. Key investors include Brooks Automation, Orbimed, European Union, Ampersand Capital Partners, and PrimeValue Capital Management.
Yes. Genewiz was acquired by Brooks Automation in September 2018.
The website of Genewiz receives about 219 thousand visits a month.